| Guillain Barre s syndrome | 5211 | Guillain Barre Syndrom |
| 2002 1 | Treatment of Guillain-Barré syndrome. [12391383] QJM 95(11):717-21 (2002) |
| 1979 2 | Clinical aspects of Guillian-Barré syndrome: a review. [552572] J R Soc Med 72(9):670-3 (1979) |
| 2007 3 | Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome. [17986150] J Neurochem 103 Suppl 1(-):150-8 (2007) |
| 1998 4 | Campylobacter species and Guillain-Barré syndrome. [9665983] Clin Microbiol Rev 11(3):555-67 (1998) |
| 2006 5 | Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases. [16966405] Infect Immun 74(12):6517-27 (2006) |
| 2005 6 | Supportive care for patients with Guillain-Barré syndrome. [16087757] Arch Neurol 62(8):1194-8 (2005) |
| 2007 7 | Immunotherapy for Guillain-Barré syndrome: a systematic review. [17337484] Brain 130(Pt 9):2245-57 (2007) |
| 2003 8 | Anti-ganglioside antibodies in Guillain-Barré syndrome; useful diagnostic markers as well as possible pathogenetic factors. [12857038] Intern Med 42(6):457-8 (2003) |
| 2002 9 | Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody. [12412991] Intern Med 41(10):760-1 (2002) |
| 2001 10 | Guillain Barré syndrome. [11724912] Mol Pathol 54(6):381-5 (2001) |
| 2000 11 | Guillain-Barré syndrome. [11085768] Postgrad Med J 76(902):774-82 (2000) |
| 2011 12 | Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. [21197269] J Biomed Biotechnol 2011(-):829129 (2011) |
| 2010 13 | The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis. [20182542] J Biomed Biotechnol 2010(-):357412 (2010) |
| 2009 14 | Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. [19564393] J Physiol 587(Pt 16):3979-99 (2009) |
| 2010 15 | Guillain-Barré syndrome (GBS). [20508277] Pharmacol Rep 62(2):220-32 (2010) |
| 2003 16 | Simulation of brain death from fulminant de-efferentation. [14672276] Can J Neurol Sci 30(4):397-404 (2003) |
| 2011 17 | Treatment guidelines for Guillain-Barré Syndrome. [21847334] Ann Indian Acad Neurol 14(Suppl 1):S73-81 (2011) |
| 2009 18 | Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. [19240270] Glycobiology 19(7):676-92 (2009) |
Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth
All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.